Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5029121 | 0.92 | CCRL2 (0.50) | CCRL2 | |
| SCHEMBL5027107 | 0.89 | CCRL2 (0.51) | CCRL2MAP4K4 | |
| SCHEMBL5029067 | 0.88 | CCRL2 (0.51) | CCRL2 | |
| SCHEMBL5029577 | 0.86 | CLK4 (0.60) | CCRL2 | |
| SCHEMBL5029267 | 0.86 | CCRL2 (0.59) | CCRL2 | |
| SCHEMBL5031903 | 0.86 | IRAK4 (0.55) | CCRL2 | |
| SCHEMBL5033636 | 0.85 | CCRL2 (0.55) | CCRL2 | |
| SCHEMBL5027259 | 0.85 | CCRL2 (0.53) | CCRL2 | |
| SCHEMBL5033574 | 0.83 | CCRL2 (0.62) | CCRL2 | |
| SCHEMBL5029584 | 0.83 | CCRL2 (0.50) | CCRL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7378409-B2 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | CCL11, CCR1, CCR2 | CCRL2 15/4885MAP4K4 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.